Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 32Observational 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1Glioma 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Laser Therapy × Clear all
NCT05337397 2022-08-08

OPTIMA

Aarhus University Hospital

Recruiting
145 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT01515085 2014-05-22

LITT

Rutgers, The State University of New Jersey

Terminated
1 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡